EP2364145A4 - Dosage forms for the rapid and sustained elevation of gastric ph - Google Patents
Dosage forms for the rapid and sustained elevation of gastric phInfo
- Publication number
- EP2364145A4 EP2364145A4 EP09755268.1A EP09755268A EP2364145A4 EP 2364145 A4 EP2364145 A4 EP 2364145A4 EP 09755268 A EP09755268 A EP 09755268A EP 2364145 A4 EP2364145 A4 EP 2364145A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- gastric
- rapid
- dosage forms
- sustained elevation
- sustained
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12902908P | 2008-05-30 | 2008-05-30 | |
PCT/US2009/003281 WO2009145905A1 (en) | 2008-05-30 | 2009-05-29 | Dosage forms for the rapid and sustained elevation of gastric ph |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2364145A1 EP2364145A1 (en) | 2011-09-14 |
EP2364145A4 true EP2364145A4 (en) | 2013-11-13 |
Family
ID=41377439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09755268.1A Withdrawn EP2364145A4 (en) | 2008-05-30 | 2009-05-29 | Dosage forms for the rapid and sustained elevation of gastric ph |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2364145A4 (en) |
CA (1) | CA2740974A1 (en) |
WO (1) | WO2009145905A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
US9265732B2 (en) | 2006-03-06 | 2016-02-23 | Pozen Inc. | Dosage forms for administering combinations of drugs |
US9220698B2 (en) | 2008-09-09 | 2015-12-29 | Pozen Inc. | Method for delivering a pharmaceutical composition to patient in need thereof |
EA201290026A1 (en) | 2009-06-25 | 2012-07-30 | Астразенека Аб | A METHOD FOR TREATING A PATIENT THAT HAS A RISK OF DEVELOPMENT OF ANALISM ASSOCIATED WITH THE RECEPTION OF NONSTEROID ANTI-INFLAMMATORY MEDIA |
UA115139C2 (en) * | 2011-12-28 | 2017-09-25 | Поузен Інк. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1559612A (en) * | 2004-02-18 | 2005-01-05 | 孔庆忠 | Medicinal mixture for treating digestire system anabrosis |
US20070031497A1 (en) * | 2002-10-16 | 2007-02-08 | Orexo Ab | Gastric acid secretion inhibiting composition |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0101379D0 (en) * | 2001-04-18 | 2001-04-18 | Diabact Ab | Composition that inhibits gastric acid secretion |
US20070243251A1 (en) * | 2002-12-20 | 2007-10-18 | Rajneesh Taneja | Dosage Forms Containing A PPI, NSAID, and Buffer |
US20060165797A1 (en) * | 2005-01-12 | 2006-07-27 | Pozen Inc. | Dosage form for treating gastrointestinal disorders |
MX2009004475A (en) * | 2006-10-27 | 2009-08-12 | Univ Missouri | Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same. |
-
2009
- 2009-05-29 WO PCT/US2009/003281 patent/WO2009145905A1/en active Application Filing
- 2009-05-29 EP EP09755268.1A patent/EP2364145A4/en not_active Withdrawn
- 2009-05-29 CA CA2740974A patent/CA2740974A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070031497A1 (en) * | 2002-10-16 | 2007-02-08 | Orexo Ab | Gastric acid secretion inhibiting composition |
CN1559612A (en) * | 2004-02-18 | 2005-01-05 | 孔庆忠 | Medicinal mixture for treating digestire system anabrosis |
Non-Patent Citations (1)
Title |
---|
See also references of WO2009145905A1 * |
Also Published As
Publication number | Publication date |
---|---|
CA2740974A1 (en) | 2009-12-03 |
WO2009145905A1 (en) | 2009-12-03 |
EP2364145A1 (en) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2860A (en) | Carbazole compounds and therapeutic uses of the compounds | |
HRP20171421T1 (en) | Solid dosage forms of bendamustine | |
ZA200906946B (en) | Inhibitors of iap | |
EP1978876A4 (en) | Devices and methods for gastrointestinal stimulation | |
IL211042A0 (en) | Imidazopyridin-2-one derivatives and uses thereof | |
EP2068864A4 (en) | Therapeutic uses of urolithins | |
ZA201103635B (en) | Azaquinolinone derivatives and uses thereof | |
EP2300011A4 (en) | Therapeutic methods and compounds | |
IL201008A0 (en) | Modified release dosage forms of tacrolimus | |
EP2387572A4 (en) | Protein kinase c inhibitors and uses thereof | |
IL211945A0 (en) | Dosage forms that facilitate rapid activation of zymogen | |
GB0807018D0 (en) | Antibodies and treatment | |
GB0900333D0 (en) | Imidazolidine compounds and uses thereof | |
GB0815788D0 (en) | Therapeutic antibodies | |
GB201211237D0 (en) | CDK5 inhibitors and therapeutic uses thereof | |
EP2364145A4 (en) | Dosage forms for the rapid and sustained elevation of gastric ph | |
PL2100692T5 (en) | Processing device with body made of concrete | |
IL208611A0 (en) | Device and process for the formation of microdepositions | |
GB0911970D0 (en) | Detonation devices and methods | |
ZA201000802B (en) | Process for the preparation of alfuzosin hydrochloride | |
EP2324059A4 (en) | Anti-pamp therapeutic antibodies | |
HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
PL2285780T3 (en) | Processes and compounds for the preparation of normorphinans | |
EP2385840A4 (en) | Materials and methods for the treatment of hypertension | |
IL206951A0 (en) | 3-alkyl-piperazine derivatives and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20110405 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1155655 Country of ref document: HK |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/20 20060101AFI20131003BHEP Ipc: A61K 31/4439 20060101ALI20131003BHEP Ipc: A61K 45/06 20060101ALI20131003BHEP Ipc: A61K 9/24 20060101ALI20131003BHEP Ipc: A61K 9/46 20060101ALI20131003BHEP Ipc: A61K 31/4164 20060101ALI20131003BHEP |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20131011 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20140509 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1155655 Country of ref document: HK |